Correction for Systematic Bias in Radiomics Measurements Due to Variation in Imaging Protocols.


Journal

Academic radiology
ISSN: 1878-4046
Titre abrégé: Acad Radiol
Pays: United States
ID NLM: 9440159

Informations de publication

Date de publication:
04 2022
Historique:
received: 04 08 2020
revised: 28 02 2021
accepted: 01 04 2021
pubmed: 17 6 2021
medline: 11 3 2022
entrez: 16 6 2021
Statut: ppublish

Résumé

The accuracy of measured radiomics features is affected by CT imaging protocols. This study aims to ascertain if applying bias corrections can improve the classification performance of the radiomics features. A cohort of 144 Non-Small Cell Lung Cancer patient CT images was used to calculate radiomics features for use in predictive models of patient pathological stage. Simulation models of the tumors, matched to patient lesion qualities of size, contrast, and degree of spiculation, were used to both create and assess protocol-specific correction factors. The usefulness of correction was first assessed by applying the corrections to simulated lesion phantoms with known properties using a corrected paired Student's t-test. The sensitivity of radiomics features to correction factors was assessed by applying a library of possible theoretical correction factors to the uncorrected radiomics from the patient data. The data were then used to assess the effect of the correction on prediction performance (AUC) from a logistic regression radiomics model across the patient cases. The correction factors were shown to reduce the bias of radiomics features, caused by protocols, provided that the correction factors were derived from lesion models with similar properties. The sensitivity of the radiomics features to changes due to protocol effects was on average 89% among all features. The corrections applied to patient data resulted in a small increase of 0.0074 in AUC that was not statistically significant (p=0.60). Protocol-specific correction factors can be applied to radiomics studies to control for biases introduced by different imaging protocols. The correction factors should ideally be lesion-specific, derived using lesion models that echo patient lesion characteristics in terms of size, contrast, and degree of spiculation. Small corrections in the 10% range offers only a small improvement in the predictability of radiomics.

Identifiants

pubmed: 34130922
pii: S1076-6332(21)00206-3
doi: 10.1016/j.acra.2021.04.012
pmc: PMC8665935
mid: NIHMS1702789
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e61-e72

Subventions

Organisme : NIBIB NIH HHS
ID : P41 EB028744
Pays : United States
Organisme : NIBIB NIH HHS
ID : R01 EB001838
Pays : United States

Informations de copyright

Copyright © 2021 The Association of University Radiologists. Published by Elsevier Inc. All rights reserved.

Références

Radiology. 2016 Feb;278(2):563-77
pubmed: 26579733
PLoS One. 2017 Sep 21;12(9):e0178524
pubmed: 28934225
J Med Imaging (Bellingham). 2019 Jul;6(3):033503
pubmed: 31338387
Transl Oncol. 2014 Feb 01;7(1):88-93
pubmed: 24772211
Phys Med Biol. 2014 Nov 7;59(21):6637-57
pubmed: 25325156
Phys Med Biol. 2007 Jul 21;52(14):4027-46
pubmed: 17664593
Invest Radiol. 2015 Nov;50(11):757-65
pubmed: 26115366
AJR Am J Roentgenol. 2015 Jul;205(1):W93-9
pubmed: 26102424
Invest Radiol. 2019 May;54(5):288-295
pubmed: 30570504
Sci Data. 2018 Oct 16;5:180202
pubmed: 30325352
Radiology. 2019 Apr;291(1):53-59
pubmed: 30694160
J Med Imaging (Bellingham). 2019 Jan;6(1):013504
pubmed: 30944842
J Med Imaging (Bellingham). 2020 Jan;7(1):014504
pubmed: 32118090
Med Phys. 2015 Aug;42(8):4941-53
pubmed: 26233220
Eur J Radiol Open. 2018 Mar 08;5:35-40
pubmed: 29719856
Sci Rep. 2018 Aug 29;8(1):13047
pubmed: 30158540
Radiology. 2009 Jul;252(1):263-72
pubmed: 19561260
IEEE Trans Med Imaging. 2019 Jun;38(6):1457-1465
pubmed: 30561344
Med Phys. 2015 Feb;42(2):1098-118
pubmed: 25652522

Auteurs

Jocelyn Hoye (J)

Carl E. Ravin Advanced Imaging Laboratories, 2424 Erwin Rd, Suite 302, Durham, North Carolina, 27705, USA; Duke University Medical Physics Graduate Program, 2424 Erwin Rd, Suite 302, Durham, North Carolina, 27705, USA; Duke University Department of Radiology, 2424 Erwin Rd, Suite 302, Durham, North Carolina, 27705, USA.

Taylor Smith (T)

Carl E. Ravin Advanced Imaging Laboratories, 2424 Erwin Rd, Suite 302, Durham, North Carolina, 27705, USA; Duke University Medical Physics Graduate Program, 2424 Erwin Rd, Suite 302, Durham, North Carolina, 27705, USA; Duke University Department of Radiology, 2424 Erwin Rd, Suite 302, Durham, North Carolina, 27705, USA.

Ehsan Abadi (E)

Carl E. Ravin Advanced Imaging Laboratories, 2424 Erwin Rd, Suite 302, Durham, North Carolina, 27705, USA; Duke University Department of Radiology, 2424 Erwin Rd, Suite 302, Durham, North Carolina, 27705, USA.

Justin B Solomon (JB)

Duke University Medical Physics Graduate Program, 2424 Erwin Rd, Suite 302, Durham, North Carolina, 27705, USA; Duke Clinical Imaging Physics Group, 2424 Erwin Rd, Suite 302, Durham, North Carolina, 27705, USA.

Ehsan Samei (E)

Carl E. Ravin Advanced Imaging Laboratories, 2424 Erwin Rd, Suite 302, Durham, North Carolina, 27705, USA; Duke University Medical Physics Graduate Program, 2424 Erwin Rd, Suite 302, Durham, North Carolina, 27705, USA; Duke University Department of Radiology, 2424 Erwin Rd, Suite 302, Durham, North Carolina, 27705, USA; Duke Clinical Imaging Physics Group, 2424 Erwin Rd, Suite 302, Durham, North Carolina, 27705, USA; Duke University Department of Physics, 2424 Erwin Rd, Suite 302, Durham, North Carolina, 27705, USA; Duke University Department of Biomedical Engineering, 2424 Erwin Rd, Suite 302, Durham, North Carolina, 27705, USA; Duke University Department of Electrical and Computer Engineering, 2424 Erwin Rd, Suite 302, Durham, North Carolina, 27705, USA. Electronic address: ehsan.samei@duke.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH